This document does not set out to convince. It sets out to be verifiable. What we measured in the field, with which instruments, under which conditions — and above all what those conditions do not allow us to conclude.
The limits of our observations take up as much room here as the results. That is deliberate. The controlled protocols we plan are described in this document, with their state of progress — we will publish the results, including negative ones.
6 subjects, 4 muscle groups. It is preferentially the weaker side that improves.
Individual gain percentages are not interpretable until the detection threshold of the protocol is established. They are therefore not used as headline figures: they are recorded further down, in the detailed measurements, with their status.
Every observation on this page carries its level of certainty. An exploratory result never moves up a rung.
Verifiable by a third party, independently of us. It is the only level we rely on without reservation.
Under uncontrolled conditions. Descriptive — not conclusive. Almost all of this document sits here.
Stated because it guides the research. Not demonstrated, and presented as such.
The “without” measurement always precedes the “with” measurement. A simple learning or warm-up effect may therefore contribute to the result.
No indistinguishable placebo condition was used in the strength series.
The subject and the operator both know what is being worn. Expectation can influence a voluntary performance.
We have not yet measured the smallest difference our protocol allows us to claim as real. That is a gap, and we write it rather than let it be guessed. The reliability study that will produce this figure is the first protocol we will run.
Before saying what we measure, we have to say why this parameter. Left/right strength asymmetry is an established clinical object, with its thresholds, its tests and its decisions.
Passing the full return-to-sport battery — score > 90 on the KOS-ADL, the global rating of function, quadriceps strength symmetry and hop tests — was associated with 5.6% reinjury versus 38.2% on failure (HR 0.16), without reaching statistical significance (p = 0.075). More symmetrical quadriceps strength before return did significantly reduce the reinjury rate.
Failing to meet the discharge criteria, symmetry among them, is associated with a fourfold risk of graft rupture.
In acute unilateral low back pain: multifidus asymmetry of 31% ± 8% on the symptomatic side, against less than 5% in healthy subjects. The atrophy matched the symptomatic vertebral level in 24 patients out of 26.
Multifidus recovery is not automatic after resolution of a first episode of acute low back pain.
Multifidus volume reduced by 18.1% at the L5-S1 level, in active individuals.
The pain goes away.
The asymmetry stays.
It has been published since 1996, and it is the reason we measure this parameter rather than another: it persists after the symptom has gone, and it can be tracked over time.
Schematic, after the pattern described by Hides et al. (1996). The curves illustrate the dissociation between the two parameters; this is not a data plot, and the values are not to scale.
Hides 1994 states it directly: no correlation between the degree of asymmetry and the severity of symptoms. More asymmetry does not mean more pain.
The direction of causality is not established. Does asymmetry promote pain, or does pain inhibit the muscle? Reflex muscle inhibition linked to pain is well documented, and argues rather for the second direction.
The 10-15% threshold used in sport is not always substantiated: fifteen articles out of eighteen use it without correctly referencing its origin, and the reported effects on injury and performance are inconsistent.
Findings were highly inconsistent; the authors conclude that no clear recommendation can be made on the relationship between asymmetry and injury. Some included cohorts report an association around 15%, others do not.
No increase in hamstring injury risk at 10, 15 or 20% asymmetry — a result contradicting other work.
They forbid claiming that asymmetry causes pain. We do not claim it.
Asymmetry remains measurable, it persists, and restoring it is a recognised rehabilitation objective.
A series of isometric strength tests on a Kinvent dynamometer, across 6 independent subjects and 4 muscle groups.
An ordinary warm-up lifts both sides comparably. That is not what we observe here: it is the weaker side that improves the most, systematically, across 6 subjects and 4 different muscle groups. The result is not an overall increase — it is a rebalancing.
Improvement on both sides, more marked on the left.
Weaker side: strongest improvement.
Weaker side: strongest improvement.
Weaker side: strongest improvement.
Net gain on the weaker side.
Consistent with the series.
Strong response on the weaker side.
This pattern — the rebalancing, not the increase — is not what a simple uniform bilateral warm-up would produce. It nonetheless remains entirely compatible with regression to the mean, measurement noise and the fixed order of trials. And it is the pattern, not the percentages, that justifies moving to a controlled study.
Measuring a left/right gap twice in a row statistically produces a decrease, with no intervention at all.
The side that measures lower is more likely to be the one measurement noise pulled down.
It returns towards its true value. Mechanically, the weaker side is the one that "improves" most.
Asymmetry decreases — exactly the pattern we observe, with no circuit involved at all.
This explanation accounts both for the reduction in asymmetry and for the fact that the weaker side improves most — that is, exactly the pattern we observe. We cannot rule it out as things stand.
Randomise the order of conditions. No condition may be systematically measured second.
PlannedRun blinded, against a sham circuit. Neither subject nor operator may know what is worn.
PlannedDetermine the weaker side in an earlier session. The side of interest must not be picked by the same day's measurement.
PlannedEach with its instrument, its level of evidence and its methodological limit.
Sway area at equal load, on a K-Force Plates force platform.
Measured with K-Move, before / after calibration.
In professional athletes, recorded immediately after calibration and compared with the best personal score on record for the machine. R15 Studio, Paris.
Methodological limit. A personal best is the best of a large number of attempts. Comparing it with a single measurement is not a balanced comparison. This observation will remain indicative until it has been repeated in a protocol comparing two series of attempts under identical conditions.
EEG, heart rate, training load, recovery. Single subject — shown to illustrate the instruments, not to conclude.
Under exposure to a mains-powered screen, the beta/alpha ratio evolved differently depending on the condition. Muse Athena EEG.
Lower values under exposure with the circuits present, compared with the same source without circuits.
Within-subject longitudinal tracking, phases with / without. Subject = founder · conflict of interest declared.
Daily minima raised over the period observed, via wearable. Subject = founder · COI declared.
The magnitude of the response varies considerably from one person to another. Our field observations led us to identify four distinct response configurations.
The engraved plates name the register. Omega exists in two orientations — arrow up and arrow down are two distinct calibrations. Go is a separate range, with no profile determination.
A calibration that does not match a person’s profile yields results below what they could obtain. That is why the profile is determined beforehand, and is not chosen.
The Perfect Posture Test — 15 minutes, with a certified tester — identifies the profile and enables the matching calibration.
Profile distribution observed in two very different settings.
A circuit bought without a test has little chance of matching. In a clinical setting, a person taken at random has roughly a one-in-ten chance of falling into the Alpha register, and one in four into the Theta register.
That is why the Q-Pro range goes through a test. It is not a commercial constraint: it is what makes the product relevant.
A system in which choosing the wrong profile explains a failure is hard to catch out. And a fourth profile that takes in precisely the cases the other three do not explain makes that objection stronger still. We name it for that reason.
Our chrysalis-state hypothesis does, however, carry a consequence that can be tested. If Harmonia is a stage and not a category, some of the people it covers must show a defined profile on a later test. A retest at six and twelve months answers the question. If the conversion rate is zero, the hypothesis is wrong, and we will publish that.
Across roughly 5,000 sessions since 2023, we record on the order of one session in two hundred with no correction across the three planes under our current criteria — criteria that were not pre-registered. Our answer remains a pre-registered study, whose plan must explicitly include the Harmonia case. Without that, the fourth profile would become an adjustment variable absorbing every failure.
We predict that the response to the circuit matching the profile will be greater.
If it is not, our profile grid is wrong — and we will publish that.
A trained reader looks first for what is missing. Here is our list, before anyone asks for it.
About one person in two hundred does not fall under any of the three calibrated profiles.
When the Perfect Posture Test identifies one of the three — Q-Alpha, Q-Theta or Q-Omega — the postural correction we observe spans all three planes. In roughly one person in two hundred, none of the three produces that result. Those people fall under the fourth profile, Harmonia, and receive the universal signature — the one used in Q-Go.
Harmonia is not an exception, it is a state: a system that has not yet differentiated toward one of the three registers. We call it the chrysalis state, and the image says what it should — a stage, not a defect.
What we do not know: whether that state evolves. If the hypothesis holds, some of these people should show a defined profile on a later test. We have not measured this. It is one of the reasons profile stability over time sits among our open questions.
We say it before the sale, not after.
Outside a controlled protocol, without systematic counting. We will publish this rate as soon as a standardised series allows it to be established.
It is also what makes the universal signature recommendable without a test. It is optimal for no one and compatible with everyone: it is the only one of the four whose assignment does not depend on a prior determination.
A test-retest reliability study, within- and between-operator, is the first protocol we will run. It has not started. Until that figure exists, we cannot claim that any given difference is significant.
Sham-controlled, double-blind protocols are in preparation, with an independent third party holding the key alone.
A retest at six and twelve months would answer the question. The protocol is described; it has not started.
And not only for us: the debate on the action of weak fields on living systems is open in the scientific literature. We therefore base nothing on it.
Protocols are written before the first measurement — question, single primary metric, sample size, analysis plan.
An independent third party prepares the coded conditions and holds the key alone. Without that, a study is not blinded.
We will publish the results, including negative ones. A null result is information.
The principle our circuits rest on is not a secret. It is in the public domain.
Perfect Posture Test · 15 minutes · before / after, in front of you. With a certified tester, in practice or by video call. The test identifies your biophysical profile and enables the matching calibration. Its cost is deducted from your order.
As our data stands, buying is a matter of trust, not of proof.
We write it because it is true, and because the randomised, blinded replication against a sham circuit — which we have planned — is the only test that can change that sentence.
All our pilot studies are freely downloadable, in French and English, methodology and limits included, from our science hub. We have nothing to hide — we simply still have a great deal to measure.